Enacuity

Software-only hyperspectral imaging for the operating theatre

Enacuity are building the first software-only hyperspectral imaging solution for real-time surgical image enhancement.

This technology aims to reduce complications in minimally-invasive surgery by transforming standard surgical cameras into powerful hyperspectral imaging tools, without the need for costly hardware upgrades.

It enables surgeons to see tissue perfusion and critical structures more clearly, improving patient outcomes.

This spinout is a collaboration with Imperial.

The Enacuity journey so far:

2023: Enacuity is founded
2024: Rasied £1.28 million pre-seed funding
2025: Received Innovate UK Smart Grant worth £300,840

Team

Dr Maria Leiloglou

Founder and CEO

MedTech Innovator specialised in the development and clinical translation of surgical imaging equipment. Honorary Research Fellow within UCL Engineering.

Professor Danail Stoyanov, Scientific Advisor (UCL)

Professor Daniel Elson, Scientific Advisor (Imperial)

Dr Tobias Czempiel, Chief Technology Officer

Dr Weng Sie Wong

Senior Business Manager

Dr Wong brings extensive experience of all aspects of university technology transfer activities from strategic IP management to licence negotiations and spinout formation.

As a Senior Business Manager focusing on the commercialisation of medical technologies, healthcare engineering, medical imaging and AI-enabled healthcare innovations arising from UCL research, she has been involved in the formation of multiple spinouts and acted as a director on various boards.

Prior to joining UCL Ventures, Dr Wong was a senior technology transfer manager at Oxford University’s TTO, Oxford University Innovation, working on a diverse range of both life and physical science projects over a 10-year period.

Weng holds an MBA from Edinburgh University and a PhD in pharmacology from UCL.